| 产品描述: | Kartogenin (KGN) sodium is an inducer of chondrogenic tissue formation (EC50: 100 nM). Kartogenin sodium induces chondrogenesis by binding to fibrin A, disrupting its interaction with the transcription factor core binding factor beta subunit (CBFβ), and by modulating the CBFβ-RUNX1 transcriptional program. Kartogenin sodium also promotes tendon-bone junction (TBJ) wound healing by stimulating collagen synthesis. Kartogenin sodium is widely used in cell-free therapy in the field of regeneration for cartilage regeneration and protection, tendon-bone healing, wound healing and limb development. Kartogenin sodium promotes cartilage repair, coordinates limb development, and is also used in osteoarthritis (OA) research. |
| 体外研究: |
Kartogenin sodium(100 nM;72 h)诱导原代 hMSC 中软骨细胞结节的形成。 Kartogenin sodium(10 nM-10 μM;72 h)可增加 hMSC 中软骨细胞特异性基因的表达。 Kartogenin sodium(0.12-10 μM;48 h)可抑制原代牛关节软骨细胞中细胞因子诱导的一氧化氮 (NO) 和糖胺聚糖 (GAG) 释放。 Kartogenin sodium(50-5000 nM;2 wk)以浓度依赖性方式诱导 BMSC 的软骨分化。 |
| 体内研究: |
Kartogenin sodium(10 μM,溶于 4μL 盐水中;在第 7 天和第 21 天处理)可促进胶原酶 VII 诱导的小鼠 OA 模型中的软骨修复。 |
| 保存条件: |
2-8°C, 干燥, 避光 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.947 ml |
14.735 ml |
29.471 ml |
| 5 mM |
0.589 ml |
2.947 ml |
5.894 ml |
| 10 mM |
0.295 ml |
1.474 ml |
2.947 ml |
| 50 mM |
0.059 ml |
0.295 ml |
0.589 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |